GlassScriptPhysician profile
Travis P Erickson
NPI 1467927657
$1,648.48
in general payments reported to CMS, 2019-2025
19 companies · $578 in 2025
The $578 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $90.61 · 2023: $372 · 2024: $608 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $448.94 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $392.19 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $126.28 | 2023-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $90.15 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $79.74 | 2022-2024 | Xarelto |
| Abbott Laboratories | $71.93 | 2024-2025 | Gallant, Xience Skypoint, Cardiomems |
| Amgen INC. | $69.03 | 2022-2024 | Repatha |
| Baxter Healthcare | $52.95 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $52.92 | 2023-2024 | Verquvo |
| Novo Nordisk INC | $41.90 | 2023-2024 | Rybelsus, Ozempic |
| Alnylam Pharmaceuticals INC. | $38.28 | 2025 | Amvuttra |
| Pfizer INC. | $36.18 | 2022-2025 | |
| Philips North America LLC | $33.32 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Boston Scientific Corporation | $29.77 | 2023-2024 | Watchman Flx |
| Getinge USA Sales, LLC | $23.63 | 2023 | Sensation 7fr. 34cc Iab |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.22 | 2025 | |
| Medtronic, INC. | $14.92 | 2025 | In.Pact Admiral |
| Actelion Pharmaceuticals US, INC. | $14.70 | 2025 | Uptravi, Opsumit |
| Daiichi Sankyo INC. | $14.43 | 2023 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.